Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q8WZA1 (PMGT1_HUMAN)

Last modified July 7, 2009. Version 61. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1
      Short name=POMGnT1
    EC=2.4.1.-
Alternative name(s):
    UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2
      Short name=GnT I.2
Gene names
Name: POMGNT1
Synonyms: MGAT1.2
ORF Names: UNQ746/PRO1475
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length660 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Participates in O-mannosyl glycosylation. May be responsible for the synthesis of the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety on alpha-dystroglycan and other O-mannosylated proteins. Is specific for alpha linked terminal mannose and does not have MGAT3, MGAT4, MGAT5, MGAT7 or MGAT8 activity.

Catalytic activity

UDP-N-acetyl-D-glucosamine + Man-R = N-acetyl-D-glucosamine-beta-1,2-Man-R + UDP.

Cofactor

Manganese.

Pathway

Protein modification; protein glycosylation.

Subcellular location

Golgi apparatus membrane; Single-pass type II membrane protein Potential.

Tissue specificity

Constitutively expressed. An additional weaker band is also detected in spinal cord, lymph node, and trachea. Expressed especially in astrocytes. Also expressed in immature and mature neurons. Ref.1 Ref.7

Domain

Amino acid residues between 299-311 are important for both protein expression and enzymatic activity. The minimal catalytic domain is located between positions 299-651. Single amino acid substitutions in the stem domain from MEB patients abolished the activity of the membrane-bound form but not the soluble form. This suggests that the stem domain of the soluble form is unnecessary for activity, but that some amino acids play a crucial role in the membrane-bound form. Ref.10

Involvement in disease

Defects in POMGNT1 are the cause of muscle-eye-brain disease (MEB) [MIM:253280]. MEB is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, cobblestone lissencephaly and cerebellar hypoplasia. MEB patients present severe congenital myopia, congenital glaucoma, pallor of the optic disks, retinal hypoplasia, mental retardation, hydrocephalus, abnormal electroencephalograms, generalized muscle weakness and myoclonic jerks. Ref.1 Ref.10 Ref.2 Ref.9 Ref.11 Ref.12

Defects in POMGNT1 are a cause of Walker-Warburg syndrome (WWS) [MIM:236670]; also known as hydrocephalus-agyria-retinal dysplasia or HARD syndrome. WWS is an autosomal recessive disorder characterized by cobblestone lissencephaly, hydrocephalus, agyria, retinal displasia, with or without encephalocele. It is often associated with congenital muscular dystrophy and usually lethal within the first few months of life. Ref.2

Sequence similarities

Belongs to the glycosyltransferase 13 family.

Biophysicochemical properties

Kinetic parameters:

KM=1.85 mM for mannosylpeptide

KM=0.73 mM for UDP-GlcNAc

KM=30 mM for Man(alpha1-)O-benzyl

KM=12 mM for CYA[Man(alpha1-)O-T]AV

pH dependence:

Optimum pH is 6.0.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 660660Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1
PRO_0000191390

Regions

Topological domain1 – 3737Cytoplasmic Potential
Transmembrane38 – 5821Signal-anchor for type II membrane protein Potential
Topological domain59 – 660602Lumenal Potential
Compositional bias263 – 2675Poly-Arg

Amino acid modifications

Cross-link537Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.8
Cross-link538Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.8

Natural variations

Natural variant2231E → K in MEB; specific activity abolished in the membrane bound form but not the soluble form. Ref.10 Ref.2 Ref.9
VAR_023101
Natural variant2501E → V: dbSNP rs17855359. Ref.6
VAR_030645
Natural variant2651R → H in MEB; found on the same allele as Q-311; could be a polymorphism. Ref.11
VAR_023102
Natural variant2691C → Y in MEB; specific activity abolished of the membrane bound form but not the soluble form. Ref.10 Ref.2 Ref.9
VAR_023103
Natural variant3111R → Q in MEB; found on the same allele as H-265; could be a polymorphism. Ref.11
VAR_023104
Natural variant4251W → S in MEB. Ref.12
VAR_023105
Natural variant4421R → C in MEB. dbSNP rs28940869. Ref.11
VAR_023106
Natural variant4901C → Y in MEB. Ref.12
VAR_023107
Natural variant4931P → R in MEB; specific activity abolished. Ref.1 Ref.9
VAR_023108
Natural variant5041V → I: dbSNP rs17102066.
VAR_030646
Natural variant5501S → N in MEB. Ref.1
VAR_023109
Natural variant6231V → M: dbSNP rs6659553. Ref.5
VAR_023110

Sequences

Sequence LengthMass (Da)Tools
Q8WZA1-1 [UniParc].

Last modified March 1, 2002. Version 1.
Checksum: B28D0E543E162B46

FASTA66075,220
        10         20         30         40         50         60 
MDDWKPSPLI KPFGARKKRS WYLTWKYKLT NQRALRRFCQ TGAVLFLLVT VIVNIKLILD 

        70         80         90        100        110        120 
TRRAISEANE DPEPEQDYDE ALGRLEPPRR RGSGPRRVLD VEVYSSRSKV YVAVDGTTVL 

       130        140        150        160        170        180 
EDEAREQGRG IHVIVLNQAT GHVMAKRVFD TYSPHEDEAM VLFLNMVAPG RVLICTVKDE 

       190        200        210        220        230        240 
GSFHLKDTAK ALLRSLGSQA GPALGWRDTW AFVGRKGGPV FGEKHSKSPA LSSWGDPVLL 

       250        260        270        280        290        300 
KTDVPLSSAE EAECHWADTE LNRRRRRFCS KVEGYGSVCS CKDPTPIEFS PDPLPDNKVL 

       310        320        330        340        350        360 
NVPVAVIAGN RPNYLYRMLR SLLSAQGVSP QMITVFIDGY YEEPMDVVAL FGLRGIQHTP 

       370        380        390        400        410        420 
ISIKNARVSQ HYKASLTATF NLFPEAKFAV VLEEDLDIAV DFFSFLSQSI HLLEEDDSLY 

       430        440        450        460        470        480 
CISAWNDQGY EHTAEDPALL YRVETMPGLG WVLRRSLYKE ELEPKWPTPE KLWDWDMWMR 

       490        500        510        520        530        540 
MPEQRRGREC IIPDVSRSYH FGIVGLNMNG YFHEAYFKKH KFNTVPGVQL RNVDSLKKEA 

       550        560        570        580        590        600 
YEVEVHRLLS EAEVLDHSKN PCEDSFLPDT EGHTYVAFIR MEKDDDFTTW TQLAKCLHIW 

       610        620        630        640        650        660 
DLDVRGNHRG LWRLFRKKNH FLVVGVPASP YSVKKPPSVT PIFLEPPPKE EGAPGAPEQT 

« Hide

References

« Hide 'large scale' references
[1]"Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1."
Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., Herrmann R., Straub V., Talim B., Voit T., Topaloglu H., Toda T., Endo T.
Dev. Cell 1:717-724(2001) [PubMed: 11709191] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, VARIANTS MEB ARG-493 AND ASN-550.
Tissue: Brain.
[2]"Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease."
Taniguchi K., Kobayashi K., Saito K., Yamanouchi H., Ohnuma A., Hayashi Y.K., Manya H., Jin D.K., Lee M., Parano E., Falsaperla R., Pavone P., Coster R.V., Talim B., Steinbrecher A., Straub V., Nishino I., Topaloglu H. expand/collapse author list , Voit T., Endo T., Toda T.
Hum. Mol. Genet. 12:527-534(2003) [PubMed: 12588800] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN WWS, VARIANTS MEB LYS-223 AND TYR-269.
Tissue: Brain.
[3]"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment."
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. expand/collapse author list , Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.
Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[4]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[5]"The DNA sequence and biological annotation of human chromosome 1."
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. expand/collapse author list , Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.
Nature 441:315-321(2006) [PubMed: 16710414] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT MET-623.
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT VAL-250.
Tissue: Placenta.
[7]"Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I."
Zhang W., Betel D., Schachter H.
Biochem. J. 361:153-162(2002) [PubMed: 11742540] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 84-660, TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES.
Tissue: Brain.
[8]"Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry."
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.
Proteomics 7:868-874(2007) [PubMed: 17370265] [Abstract]
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-537 AND LYS-538, MASS SPECTROMETRY.
[9]"Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease."
Manya H., Sakai K., Kobayashi K., Taniguchi K., Kawakita M., Toda T., Endo T.
Biochem. Biophys. Res. Commun. 306:93-97(2003) [PubMed: 12788071] [Abstract]
Cited for: CHARACTERIZATION OF VARIANTS MEB LYS-223; TYR-269 AND ARG-493.
[10]"Structure-function analysis of human protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1, POMGnT1."
Akasaka-Manya K., Manya H., Kobayashi K., Toda T., Endo T.
Biochem. Biophys. Res. Commun. 320:39-44(2004) [PubMed: 15207699] [Abstract]
Cited for: IDENTIFICATION OF CATALYTIC DOMAIN, CHARACTERIZATION OF VARIANTS MEB LYS-223 AND TYR-269.
[11]"POMGnT1 gene alterations in a family with neurological abnormalities."
Vervoort V.S., Holden K.R., Ukadike K.C., Collins J.S., Saul R.A., Srivastava A.K.
Ann. Neurol. 56:143-148(2004) [PubMed: 15236414] [Abstract]
Cited for: VARIANTS MEB HIS-265; GLN-311 AND CYS-442.
[12]"POMGnT1 mutation and phenotypic spectrum in muscle-eye-brain disease."
Diesen C., Saarinen A., Pihko H., Rosenlew C., Cormand B., Dobyns W.B., Dieguez J., Valanne L., Joensuu T., Lehesjoki A.-E.
J. Med. Genet. 41:E115-E115(2004) [PubMed: 15466003] [Abstract]
Cited for: VARIANTS MEB SER-425 AND TYR-490.
+Additional computationally mapped references.

Web resources

GeneReviews
GGDB

GlycoGene database

Functional Glycomics Gateway - GTase

Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1

Cross-references

Sequence databases

AB057356 mRNA. Translation: BAB71960.1.
AY358592 mRNA. Translation: AAQ88955.1.
AK000284 mRNA. Translation: BAA91053.1.
AK022727 mRNA. Translation: BAB14207.1. Different initiation.
AL672043 Genomic DNA. Translation: CAH72470.1.
BC001471 mRNA. Translation: AAH01471.1.
AF250859 mRNA. Translation: AAF71270.2.
IPIIPI00550558.
RefSeqNP_060209.3.
UniGeneHs.525134

3D structure databases

HSSPHSSP built from PDB template 1FO8 based on UniProtKB P27115.
ModBaseSearch...

Protein family/group databases

CAZyGT13. Glycosyltransferase Family 13.

PTM databases

PhosphoSiteQ8WZA1.

Proteomic databases

PRIDEQ8WZA1.

Genome annotation databases

EnsemblENSG00000085998. Homo sapiens. [Contig view]
GeneID55624.
KEGGhsa:55624.
UCSCuc001cpe.1. human.

Organism-specific databases

GeneCardsGC01M046367.
H-InvDBHIX0000544.
HGNCHGNC:19139. POMGNT1.
MIM236670. phenotype.
253280. phenotype.
606822. gene.
Orphanet588. Muscle eye brain disease.
899. Walker-Warburg syndrome.
PharmGKBPA142671161.
GenAtlasSearch...

Phylogenomic databases

HOVERGENQ8WZA1.

Gene expression databases

ArrayExpressQ8WZA1.
BgeeQ8WZA1.
CleanExHS_POMGNT1.
GermOnlineENSG00000085998. Homo sapiens.

Family and domain databases

InterProIPR004139. Glyco_trans_13.
[Graphical view]
PANTHERPTHR10468. Glyco_trans_13. 1 hit.
PfamPF03071. GNT-I. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio60240.
SOURCESearch...

Entry information

Entry namePMGT1_HUMAN
AccessionPrimary (citable) accession number: Q8WZA1
Secondary accession number(s): Q5VST2 expand/collapse secondary AC list , Q9BV55, Q9H9L8, Q9NXF9, Q9NYF7
Entry history
Integrated into UniProtKB/Swiss-Prot: August 16, 2005
Last sequence update: March 1, 2002
Last modified: July 7, 2009
This is version 61 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 1

Human chromosome 1: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PATHWAY comments

Index of metabolic and biosynthesis pathways

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents